Presbyopia Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved

Posted on
by

Presbyopia Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved

DelveInsight Business Research LLP
“Presbyopia Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Presbyopia market. A detailed picture of the Presbyopia pipeline landscape is provided, which includes the disease overview and Presbyopia treatment guidelines.

DelveInsight launched a new report on Presbyopia Pipeline Insights 2020.

“Presbyopia Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Presbyopia market. A detailed picture of the Presbyopia pipeline landscape is provided, which includes the disease overview and Presbyopia treatment guidelines. 

Presbyopia is the normal loss of near focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. It is a result of a gradual decrease in accommodative amplitude, from about 15 diopters (D) to 1 D. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the ageing process.

Request for sample pages of the report: https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight

Scope of the report

  • The Presbyopia report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Presbyopia across the complete product development cycle, including all clinical and non-clinical stages.
  • It comprises of detailed profiles of Presbyopia therapeutic products with key coverage of developmental activities, including technology, collaborations, licensing, mergers and acquisition, funding, designations and other product-related details
  • Detailed Presbyopia research and development progress and trial details, results wherever available, are also included in the pipeline study.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Presbyopia.
“Several types of surgery are available, and new techniques and technologies are making them safer and more effective. Refractive surgical procedures include conductive keratoplasty, LASIK, LASEK, and photorefractive keratectomy.”

Key pharma players involved:

1. Orasis Pharmaceuticals Ltd

2. Allergan

3. Novartis Pharmaceuticals

Click here and get access to free sample copy.

Table of contents:

1. Report Introduction

2. Presbyopia 

3. Presbyopia Current Treatment Patterns

4. Presbyopia – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Presbyopia Late Stage Products (Phase-III)

7. Presbyopia Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Presbyopia Discontinued Products

13. Presbyopia Product Profiles

14. Presbyopia Key Companies

15. Presbyopia Key Products

16. Dormant and Discontinued Products

17. Presbyopia Unmet Needs

18. Presbyopia Future Perspectives

19. Presbyopia Analyst Review  

20. Appendix

21. Report Methodology

Download our full report @https://www.delveinsight.com/report-store/presbyopia-pipeline-insight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/